University of Sheffield spinout company Diurnal announces £30 million fundraising to bring pharmaceutical products to market

A University of Sheffield spin-out company, which develops innovative treatment for patients with hormone deficiencies, will be bringing its products to market after raising £30m by selling shares on London Stock Exchange’s Alternative Investment Market. Diurnal Group plc was formed based on the research work of Professor Richard Ross, an expert in endocrinology from the…

Continue reading →